Published by IQ4I on 12th December 2018 | Ref: 1111554 | This Report Is In Stock
“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report covers all the drugs that are in various phases of development (Discovery, Preclinical and Clinical). The pipeline focuses on novel pharmacologic drugs and regenerative medicines covering, antibodies, stem cell therapies, recombinant proteins, Peptide therapies, RNA-based therapeutics and others, but excludes symptom relief drugs, wound dressing, drug delivery systems, generic combinations and radiation therapies. The report also covers some of the hot targets in research for DFU treatments and related biomarkers.
This report enables Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the DFU drugs market. The report also provide strategic insights on some of the molecules that are yet to be launched in the next few years. Some of the key sections covered in the report are given below:
DFU grading, Treatment algorithm, Patient care pathway & Visiting patterns, Clinical practice guidelines, Current SOC, Adjuvant therapies, Alternative approaches, Unmet needs, ICD/CPT codes
In this section, epidemiology of DFU is reviewed to understand potential significance and impact of the disease.
Global and US prevalence rates
Hot Targets, Pathophysiology and Biomarkers
In this section, various DFU associated targets, pathophysiology, and biomarkers are discussed. Also, covers novel targets in early research for DFU.
Forecasting model for DFU market
DFU market dynamics
DFU Market Sizing
DFU related deals & Funding scenario in DFU market
Pipeline analysis was carried to get deeper insights on various treatment modalities in discovery, preclinical and development section, pipelines from major companies were identified and potential targets were reported along with Mechanism of action, Current development status and nature of molecule. Pipeline analysis by developmental stage (Discovery to Clinical development).
Stem Cell therapies, Protein therapies , Peptide therapies and Others
Drug analysis based on mechanism (Wound healing, Neuropathy, Ischemia, Neuroischemia and infection)
Key Players Analysis
The key player’s analysis section provides an in-depth understanding of various companies working on DFU and their pipelines with development phase as well as understanding partnering strategies such as deals entered by the company.
Global key players overview
Global key players Pipeline data (Discovery, Pre-clinical and Clinical development)
Global key players deals (Collaborations, Licensing, Service agreements, grants, funds)
• Causes, Symptoms and Risk Factors
• Grading Systems
• Diagnosis and Management
• Algorithm for DFU Treatment
• Care Pathways and Patient Visiting Patterns
• Clinical Practice Guidelines
• Current Standard of Care
• Adjuvant Therapies
• Alternative Therapeutic Approaches
• Unmet needs
• ICD/CPT codes
DFU PATHOPHYSIOLOGY, TARGETS AND BIOMARKERS
• Pathophysiology of DFU
• Leading Targets
• Novel Targets
• Forecasting model
• Market dynamics
• Market sizing
• DFU Deals
• Funding Scenario
• Regulatory Guidelines
• DFU Regulatory Guidelines
• Development stage
• Molecule Type
• Clinical update on Phase 3 molecules
• Competitive Analysis
• Competitive Analysis
Stem Cell Therapies
LARGE MOLECULES (UNSPECIFIED)
DFU DRUG ANALYSIS BASED ON MECHANISM
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Buy now using our secure payment system.